The G7-18NATE peptide, in particular, has provided significant proof-of-concept evidence that inhibition of Grb7 via blocking its SH2 domain has effective anti-cancer effects in cells and animal models [24,25,26,27]. The gene discussed is GRB7; the disease is cancer.